- Reuters•22 hours ago
Italian healthcare group Bracco is working on a potential bid for the radiology supplies unit that Germany's Bayer AG is considering selling, people close to the matter said. Bracco has mandated an investment bank to find a partner for a possible joint offer for the unit, which may be valued at more than 4 billion euros (4.3 billion), they said. Bayer has not yet made a final decision on whether it will sell, but earlier this year mandated Goldman Sachs as a sellside advisor and sent out information to prospective buyers, the people said, adding that the auction had been expected to start next year.
- American City Business Journals•yesterday
Bayer AG plans to acquire a product portfolio from St. Joseph-based animal health company Boehringer Ingelheim Vetmedica Inc., the two companies jointly announced Wednesday. Once the deal is completed, Bayer would acquire BIVI's Cydectin portfolio, an anti-parasitic treatment approved for use in cattle and sheep. The deal is a further step toward Boehringer Ingelheim acquiring Merial, the animal health subsidiary of Sanofi (SNY), as part of a $25.5 billion asset swap.
- Market Realist•yesterday
The founder and president of Greenlight Capital, David Einhorn, discussed his investment ideas at the Robin Hood Investors Conference.
BAYRY : Summary for BAYER AG SPON ADR REP 1 NPV - Yahoo Finance
Bayer AG (BAYRY)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
|Day's Range||98.23 - 99.77|
|52 Week Range||91.53 - 128.90|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||16.53|
|Dividend & Yield||2.87 (3.01%)|
|1y Target Est||N/A|